You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease
SBC: EPIVAX, INC. Topic: 200ABSTRACT SignificanceGravesdiseaseGDone of the most prevalent autoimmune diseasesis caused by stimulating autoantibodiesTSAbto the Thyroid Stimulating Hormone ReceptorTSHRresulting in hyperthyroidismCurrent methods for managing hyperthyroidism in GD target excess thyroid hormone secretion by ablation or removal of the thyroid or by blocking thyroid hormone synthesisEach of these therapies is assoc ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Bayesian Inference of Spacecraft Geometry and Pose
SBC: VISION SYSTEMS INC Topic: AF17AT007Space platforms are complex dynamical systems and there are many reasons to model them from ground telescope imagery as well as from space-based sensor platforms. One key motivation is to determine the operational state and configuration of the vehicle. Key questions such as did the solar panels fail to deploy, did the object begin to tumble unexpectedly may be addressed by a sufficiently detaile ...
STTR Phase I 2017 Department of DefenseAir Force -
Evaluate Efficacy of a JNK Lead Compound IGP in an In Vivo Alzheimer's Disease Model
SBC: Imago Pharmaceuticals, Inc. Topic: NIAProject Summary Abstract It is estimated that more than million people in the U S have Alzheimerandapos s disease AD The cardinal features of AD brain pathology are accumulation of A in insoluble plaques hyperphosphorylation of tau leading to its intracellular aggregation and as a consequence of one or both neuronal dysfunction Currently no disease modifying drugs exist for AD Jun N t ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Low Cost, Quantitative, Chemical Specific Device for Illicit Drug Detection
SBC: MKS Technology Topic: NIDADESCRIPTION provided by applicant This proposal will assess the quantitative capabilities of surface enhanced Raman scattering SERS detection of cocaine and marijuana metabolites in urine samples Combining low cost instrumentation and novel chemical sensing provides an innovative new approach for diagnosing illicit drug use Current methods use a colorimetric indicator to screen specimens fo ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic Role of Inter-alpha Inhibitors in Wound Healing
SBC: PROTHERA BIOLOGICS, INC. Topic: NIAMSDESCRIPTION provided by applicant Wound healing is an intricately regulated process broadly characterized by phases of inflammation proliferation and remodeling Imbalances in any one of these phases can result in inadequate healing scar formation or in the development of chronic wounds such as diabetic ulcers Diabetic ulcers are responsible for the majority of lower extremity amputations ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Jerry the Bear: A Robotic Platform for At-Home Therapy and Education for Children with Type 1 Diabetes
SBC: SPROUTEL INC Topic: 200DESCRIPTION provided by applicant The goal of this SBIR Phase I application from Sproutel is to develop a curriculum for providing expert educational content on diabetes self management to be delivered via principles of game based learning in an appealing teddy bear robotic character designed for young children diagnosed with type diabetes mellitus Type diabetes T D affects approximately ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Novel, Ambulatory Cuff-less Non-invasive Arterial Blood Pressure Monitor
SBC: Krisara Engineering Topic: NHLBIDESCRIPTION provided by applicant The objective of this proposal is to complete the engineering development and testing of the Non Invasive Self calibrating Ambulatory Multi Modality NISAM blood pressure device to recognize hypertensive patients not currently identified using todayandapos s technology As well as providing better management of hypertensive patients by presenting a truer roun ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Electric field-assisted membranes for organic solvent nanofiltration
SBC: THERMOSOLV LLC Topic: 300DESCRIPTION provided by applicant This multi phase SBIR project targets a significant problem within the mission of the National Institute of General Medical Sciences rapid size based separation of small Da molecules in bio manufacturing The aim here is to simplify and radically improve this currently multi stage and a resource intensive process Manufacturing of active pharmaceut ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Safe, Large-Format Lithium Ion Batteries for Aircraft
SBC: Yardney Technical Products, Inc. Topic: AF141071YTP will develop technology that provides a high performance, modular Li-ion battery with: redundant safety features, safer thin, metal case cell designs; fin/micro-channel thermal control system; and an evaporating fluid system that rapidly quenches failing cells to prevent thermal runaway and fratricide. The end goal of the proposal is making a lighter, longer lasting, less expensive, safer JSF ...
SBIR Phase I 2014 Department of DefenseAir Force -
Glycoengineered baculoviruses for the production of more efficacious influenza va
SBC: Glycobac, LLC Topic: NIAIDDESCRIPTION (provided by applicant): Vaccination significantly reduces morbidity and mortality caused by annual influenza epidemics. Traditionally, influenza vaccines have been manufactured using adapted influenza virus grown in eggs. However, this methodsuffers from inherent disadvantages such as slow production and allergenic egg proteins in the final product. To avoid these drawbacks, new vacci ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health